| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |